We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
Optimizing the Treatment Continuum With a Molecular-Based Approach in HER2+ GI Cancers
June 28, 2024
13:15 - 14:15 CEST
Josep Tabernero, MD, PhD
Sara Lonardi, MD
Zev A. Wainberg, MD
Multidisciplinary Approach to Diagnosing and Managing Indolent Systemic Mastocytosis: The Changing Landscape
Cem Akin, MD, PhD
Daniel J. DeAngelo, MD, PhD
Matthew J. Hamilton, MD
Managing Indolent Systemic Mastocytosis: A Multidisciplinary Case Review
South Asians With IBD: Underrepresented and Underappreciated
Tauseef Ali, MD, FACG, AGAF
Sabina Ali, MD
Neil Nandi, MD, FACP
Tina Aswani-Omprakash, MPH
HEar My Needs: Enhancing the Patient and Provider Dialogue
Robert Rahimi, MD, MSCR
Arun B. Jesudian, MD
Collaboration and Management of HE: Establishing Foundation for Successful Outcomes
West HavEn Criteria—Meaningfulness Into Clinical Practice
How Do I Prevent Future Hospital Visits due to HE?
Patricia P. Bloom, MD
Equitable HEalth for All: Improving Care for Underserved Populations and Their Unmet Needs
Addressing the Core Unmet Needs to Our Approach for Hepatic Encephalopathy
HElp! AASLD Guidelines Related to Diagnosis of HE
The Unmet Need for HE Therapy in the African American Community – Why Is This a Concern?
Tackling the Unmet Need HEad On—What Does HE Look Like?
Practical Management of Variceal Bleeding and Hepatorenal Syndrome
Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Andrew Keaveny, MD
Don Rockey, MD
Claudin18.2: An Emerging Biomarker and Its Significance as a Therapeutic Target in G/GEJ Cancers
Samuel J. Klempner, MD
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education